Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Distribution of Carbapenemase Genes among Carbapenem-Non-Susceptible Acinetobacter baumanii Blood Isolates in Indonesia: A Multicenter Study.
Anggraini D, Santosaningsih D, Saharman YR, Endraswari PD, Cahyarini C, Saptawati L, Hayati Z, Farida H, Siregar C, Pasaribu M, Homenta H, Tjoa E, Jasmin N, Sarassari R, Setyarini W, Hadi U, Kuntaman K. Anggraini D, et al. Among authors: endraswari pd. Antibiotics (Basel). 2022 Mar 9;11(3):366. doi: 10.3390/antibiotics11030366. Antibiotics (Basel). 2022. PMID: 35326829 Free PMC article.
The clinical impact of bacterial co-infection among moderate, severe and critically ill COVID-19 patients in the second referral hospital in Surabaya.
Asmarawati TP, Rosyid AN, Suryantoro SD, Mahdi BA, Windradi C, Wulaningrum PA, Arifianto MV, Bramantono B, Triyono EA, Rusli M, Rachman BE, Marfiani E, Endraswari PD, Hadi U, Kuntaman K, Nasronudin N. Asmarawati TP, et al. Among authors: endraswari pd. F1000Res. 2021 Feb 15;10:113. doi: 10.12688/f1000research.31645.2. eCollection 2021. F1000Res. 2021. PMID: 33868645 Free PMC article.
A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections.
Purwati, Budiono, Rachman BE, Yulistiani, Miatmoko A, Nasronudin, Lardo S, Purnama YI, Laely M, Rochmad I, Ismail T, Wulandari S, Setyawan D, Rosyid AN, Setiawan HW, Wulaningrum PA, Asmarawati TP, Marfiani E, Yuniati SK, Fuadi MR, Endraswari PD, Purwaningsih, Hendrianto E, Karsari D, Dinaryanti A, Ertanti N, Ihsan IS, Purnama DS, Indrayani Y. Purwati, et al. Among authors: endraswari pd. Biochem Res Int. 2021 Feb 9;2021:6685921. doi: 10.1155/2021/6685921. eCollection 2021. Biochem Res Int. 2021. PMID: 33628506 Free PMC article.